Gugulipid Efficacy, Safety For Hypercholesterolemia Challenged By Study
This article was originally published in The Tan Sheet
Patients with hypercholesterolemia should be discouraged from taking gugulipid supplements due to the herbal's lack of efficacy and potential side effects, according to UPenn researcher Philippe Szapary, MD
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC